In vivo radionuclide generators for diagnostics and therapy
In vivo radionuclide generators make complex combinations of physical and chemical
properties available for medical diagnostics and therapy. Perhaps the best‐known in vivo …
properties available for medical diagnostics and therapy. Perhaps the best‐known in vivo …
Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran
During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
[HTML][HTML] Production of no-carrier-added Ho-166 for targeted therapy purposes
S Vosoughi, S Shirvani-Arani… - Iranian Journal of …, 2017 - irjnm.tums.ac.ir
Introduction: Holmium-166 radionuclide is one of the most effective radionuclides used for
targeted therapy with theranostic properties. One method to produce this radioisotope is via …
targeted therapy with theranostic properties. One method to produce this radioisotope is via …
Preparation of 166Dy/166Ho-chitosan as an in vivo generator for radiosynovectomy
S Vosoughi, AR Jalilian, S Shirvani-Arani… - … of Radioanalytical and …, 2017 - Springer
Abstract 166 Ho is one of the most effective radionuclides used for radiosynovectomy. One
method to deliver this radioisotope to target tissue is via the 166 Dy/166 Ho in vivo generator …
method to deliver this radioisotope to target tissue is via the 166 Dy/166 Ho in vivo generator …
Preparation of Chitosan microspheres containing 166Dy/166Ho in vivo generators and their theranostic potential
BB Cho, K Choi - Journal of Radioanalytical and Nuclear Chemistry, 2018 - Springer
Chitosan microsphere (MS) loaded with 166 Dy/166 Ho were designed for therapy of
unresectable liver tumor through an in vivo generator system. The mean size of the MS was …
unresectable liver tumor through an in vivo generator system. The mean size of the MS was …
Radiolabeled TPP with 166Dy/166Ho in vivo generator as a novel therapeutic agent
N Salek, S Vosoughi, A Bahrami Samani… - … of Radioanalytical and …, 2020 - Springer
In this study, a possible therapeutic agent was developed owning to attractive characteristic
of 166 Dy/166 Ho in-vivo generator and tumor targeting of 5, 10, 15, 20-tetrakis (phenyl) …
of 166 Dy/166 Ho in-vivo generator and tumor targeting of 5, 10, 15, 20-tetrakis (phenyl) …